Clinical Trial Update: Evaluating the Safety and Efficacy of the Maurora® DES in ICAS [NA]

View source ↗

Summary

A completed clinical trial assessed the safety and efficacy of the Maurora DES for intracranial arteriosclerosis and related stroke or transient ischemic attack…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intracranial Arteriosclerosis
• Stroke
• Transient Ischemic Attack

Drugs mentioned

• Maurora DES

Snippet

Sponsor: Beijing Tiantan Hospital | Conditions: Intracranial Arteriosclerosis, Stroke (CVA) or TIA | NA | Status: COMPLETED